Impact BioMedical Inc. Company Profile
NYSE: IBOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.48-0.20 (-4.27%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Impact BioMedical at a glance
Impact BioMedical Inc. (NYSE: IBO) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector. The company's shares have traded publicly since 2024. At a market capitalization of $38.3 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001834105, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Impact BioMedical Inc.
- Ticker
- NYSE: IBO
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2024
- Market cap
- $38.28M
- SEC CIK
- 0001834105
Companies similar to Impact BioMedical
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LITSLite Strategy Inc. | 1.27 | -9.93% | $38.62M | vs IBO |
| FLNAFilana Therapeutics Inc. | 0.8157 | -6.77% | $39.40M | vs IBO |
| NNVCNanoViricides Inc. | 1.44 | +2.86% | $36.76M | vs IBO |
| IXHLIncannex Healthcare Inc. | 3.18 | +1.27% | $39.89M | vs IBO |
| CPHIChina Pharma Holdings Inc. | 0.85 | +32.58% | $36.57M | vs IBO |
| BCTXBriaCell Therapeutics Corp. | 4.00 | -0.50% | $34.80M | vs IBO |
| VERUVeru Inc. | 2.46 | -0.40% | $41.94M | vs IBO |
| ATNMActinium Pharmaceuticals Inc. (Delaware) | 1.07 | -3.60% | $33.64M | vs IBO |